ArticleFrontiers in public health2026
Nurse-led digital therapeutics for type 2 diabetes in routine care: a retrospective cohort study of adherence, glycemic outcomes, and care continuity.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Digital therapeutics can extend diabetes self-management beyond clinic visits, but sustained engagement, safe interpretation of patient-generated data, and integration with routine care remain challenging. Objective: This study examined the real-world association between a nurse-led digital therapeutics pathway and clinical, behavioral, and patient-experience outcomes among adults with type 2 diabetes. Methods: De-identified routine-care records were used to compare a structured nurse-led digital therapeutics pathway with usual care over 24 weeks. Eligible baseline records were classified by documented routine-care pathway exposure, and outcome analyses used complete 24-week records. The nurse-led pathway included digital readiness assessment, onboarding education, adherence monitoring, tiered follow-up, feedback reports, and coordination with physicians and technical staff. Results: Complete 24-week data were available for 57 patients in the nurse-led pathway and 56 receiving usual care. Adherence was 78.3% and 54.7%, respectively (between-pathway difference, 23.6 percentage points; Conclusion: In this single-center retrospective cohort, the nurse-led digital therapeutics pathway was associated with more sustained digital engagement and more favorable metabolic and patient-reported outcomes than usual care. Prospective multicenter studies are needed before causal or broad implementation claims can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.